148
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

The Role of Widefield Optical Coherence Tomography Angiography in the Diagnosis and Management of Acute Vogt–Koyanagi–Harada Disease

, MD, , MD, , MD, , MD, PhD, , MD, PhD & , MD, PhD
Pages 391-401 | Received 20 Sep 2021, Accepted 11 Feb 2023, Published online: 01 Mar 2023

References

  • Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131(5):647–652. doi:10.1016/s0002-9394(01.
  • Rao NA, Gupta A, Dustin L, et al. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. Ophthalmology. 2010;117(3):591–599. doi:10.1016/j.ophtha.2009.08.030.
  • Rao NA. Treatment of Vogt-Koyanagi-Harada disease by corticosteroids and immunosuppressive agents. Ocul Immunol Inflamm. 2006;14(2):71–72. doi:10.1080/09273940600674368.
  • Luo KD, Cai HM, Hu YX, et al. Distinguishing microvasculature features of Vogt-Koyanagi-Harada in patients in acute and convalescent phases using optical coherence tomography angiography. Ocul Immunol Inflamm. 2020. doi:10.1080/09273948.2019.1695856.
  • Fan SP, Lin D, Hu JJ, et al. Evaluation of microvasculature alterations in convalescent Vogt-Koyanagi-Harada disease using optical coherence tomography angiography. Eye. 2020. doi:10.1038/s41433-020-01210-5.
  • Aggarwal K, Agarwal A, Mahajan S, et al. The role of optical coherence tomography angiography in the diagnosis and management of Acute Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2018;26(1):142–153. doi:10.1080/09273948.2016.1195001.
  • Tian M, Wolf S, Munk MR, Schaal KB. Evaluation of different Swept’Source optical coherence tomography angiography (SS-OCTA) slabs for the detection of features of diabetic retinopathy. Acta Ophthalmol. 2020;98(4):e416–e420. doi:10.1111/aos.14299.
  • da Silva FT, Damico FM, Marin ML, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: considerations on the different disease categories. Am J Ophthalmol. 2009;147(2):339–345 e335. doi:10.1016/j.ajo.2008.08.034.
  • Kawaguchi T, Horie S, Bouchenaki N, Ohno-Matsui K, Mochizuki M, Herbort CP. Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2010;30(1):41–50. doi:10.1007/s10792-008-9288-1.
  • Du L, Kijlstra A, Yang P. Vogt-Koyanagi-Harada disease: novel insights into pathophysiology, diagnosis and treatment. Prog Retin Eye Res. 2016;52:84–111. doi:10.1016/j.preteyeres.2016.02.002.
  • Hashizume K, Imamura Y, Fujiwara T, Machida S, Ishida M, Kurosaka D. Choroidal thickness in eyes with posterior recurrence of Vogt-Koyanagi-Harada disease after high-dose steroid therapy. Acta Ophthalmol. 2014;92(6):e490–491. doi:10.1111/aos.12384.
  • Lin YC, Lo KJ, Chen SJ, Hwang DK. Ocular syphilis mimicking Vogt-Koyanagi-Harada disease. Taiwan J Ophthalmol. 2019;9(4):271–275. doi:10.4103/tjo.tjo_63_19.
  • Aggarwal K, Agarwal A, Deokar A, et al. Distinguishing features of acute Vogt-Koyanagi-Harada disease and acute central serous chorioretinopathy on optical coherence tomography angiography and en face optical coherence tomography imaging. J Ophthalmic Inflamm Infect. 2017;7(1):3. doi:10.1186/s12348-016-0122-z.
  • Kalogeropoulos D, Kitsos G, Konstantinidis A, et al. Tuberculous posterior sclero-uveitis with features of Vogt-Koyanagi-Harada uveitis: an unusual case. Am J Case Rep. 2017;18:367–374. doi:10.12659/ajcr.903304.
  • Fukutsu K, Namba K, Iwata D, et al. Pseudo-inflammatory manifestations of choroidal lymphoma resembling Vogt-Koyanagi-Harada disease: case report based on multimodal imaging. BMC Ophthalmol. 2020;20(1):94. doi:10.1186/s12886-020-01353-9.
  • Kitamura Y, Oshitari T, Kitahashi M, Baba T, Yamamoto S. Acute posterior multifocal placoid pigment epitheliopathy sharing characteristic OCT findings of Vogt-Koyanagi-Harada disease. Case Rep Ophthalmol Med. 2019;2019:9217656. doi:10.1155/2019/9217656.
  • Ingolotti M, Schlaen BA, Roig Melo-Granados EA, Ruiz García H, Aguilera Partida JA. Azathioprine during the first trimester of pregnancy in a patient with Vogt-Koyanagi-Harada disease: a multimodal imaging follow-up study. Am J Case Rep. 2019;20:300–305. doi:10.12659/ajcr.914281.
  • Wintergerst MWM, Herrmann P, Finger RP. Optical coherence tomography angiography for evaluation of Sattler’s Layer in Vogt-Koyanagi-Harada disease. Ophthalmic Surg Lasers Imaging Retina. 2018;49(8):639–642. doi:10.3928/23258160-20180803-14.
  • Parrulli S, Invernizzi A, Monteduro D, et al. Longitudinal follow-up of choroidal granulomas with indocyanine green angiography and optical coherence tomography angiography: a lesion-based analysis. Retina. 2022;42(5):906–914. doi:10.1097/iae.0000000000003405.
  • Pichi F, Smith SD, Neri P, et al. Granulomas visualized by swept-source optical coherence tomography angiography. Retina. 2021;41(3):602–609. doi:10.1097/iae.0000000000002864.
  • Karaca I, Yılmaz SG, Afrashi F, Nalçacı S. Assessment of macular capillary perfusion in patients with inactive Vogt-Koyanagi-Harada disease: an optical coherence tomography angiography study. Graefes Arch Clin Exp Ophthalmol. 2020;258(6):1181–1190. doi:10.1007/s00417-020-04676-x.
  • Fan S, Lin D, Hu J, et al. Evaluation of microvasculature alterations in convalescent Vogt-Koyanagi-Harada disease using optical coherence tomography angiography. Eye (Lond). 2020. doi:10.1038/s41433-020-01210-5.
  • Khan HA, Shahzad MA, Iqbal F, et al. A novel method of quantifying the choriocapillaris in normal and post-inflammatory eyes. Ocul Immunol Inflamm. 2020;1–7. doi:10.1080/09273948.2020.1800047.
  • Cerquaglia A, Lupidi M, Fiore T, Iaccheri B, Perri P, Cagini C. Deep inside multifocal choroiditis: an optical coherence tomography angiography approach. Int Ophthalmol. 2017;37(4):1047–1051. doi:10.1007/s10792-016-0300-x.
  • Scarinci F, Varano M, Parravano M. Resilience of the photoreceptors in posterior multifocal placoid pigment epitheliopathy observed by microperimetry over time. Ocul Immunol Inflamm. 2020;1–7. doi:10.1080/09273948.2020.1817502.
  • Lai TY, Chan RP, Chan CK, Lam DS. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease. Eye (Lond). 2009;23(3):543–548. doi:10.1038/eye.2008.89.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.